BioSpace News Archive

Nova today announced financial results for the third quarter 2018, the period ended September 30, 2018.

Cellect Biotechnology Ltd. announced today its CEO Dr. Shai Yarkoni will present at the 24th Annual Bio Europe Conference.

Review Conducted by EY-Parthenon Highlights Need for Better Tools to Help Smokers Kick the Habit

Opened Expansion Cohorts in Phase 1 Trial Evaluating SY-1365 in Multiple Ovarian and Breast Cancer Populations as Single Agent and in Combination

Category Disruption Possible from Smaller Vendors, Including PatientSafe

Indivior PLC today announced that its financial results for the period ended September 30, 2018.

Evofem Biosciences, Inc., (NASDAQ: EVFM) (“Evofem” or the “Company”), a clinical-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women’s sexual and reproductive health, today announced it will host a key opinion leader event in New York City on Thursday, November 15, 2018

On World Pancreatic Cancer Day, Thursday, Nov. 15, people around the world will rally together to Demand BetterSM in the fight against pancreatic cancer, starting with awareness of the symptoms and risks.

AAVP Biosystems, Inc. a developmental stage gene delivery company initially focused on the pursuit of a new therapy for cancer indications, is now named PhageNova Bio, Inc.

Alpha-1 awareness matters. Alpha-1 (alpha-1- antitrypsin deficiency) is a genetic condition that may result in serious, chronic lung disease in adults, including an increased risk of developing emphysema, and is the most commonly known genetic risk factor for chronic obstructive pulmonary disease